Immuno-Multi-Therapy and Prophylaxis Efficacy against COVID-19
Journal Title: Journal of Clinical Immunology & Microbiology - Year 2021, Vol 2, Issue 1
Abstract
In the context of the current COVID-19 pandemic, strategies for finding effective therapies advocate the so-called "therapeutic repositioning" approach, i.e., the use of existing molecules on the pharmaceutical market, whose toxicity and therapeutic efficacy are known. The immunotherapy proposed in this study consisted to use four well-known components of validated therapeutic drugs, namely: interferon type 1 (IFNα), interferon type 2 (IFNγ), chloroquine (Chloroquine phosphate) and antioxidants (Vitamins A, C, E, trace elements and lycopene). Such non pathogen specific treatment was curative and preventive (i.e., prophylaxis), and expected to enhance the patient's innate response. A selected cohort consisted of 122 patients tested positive by RT-PCR (SARS-CoV-2 infection). Among them, 89 patients were asymptomatic and 43 symptomatic (COVID-19). Due to the compassionate nature of this therapeutic approach, age, and gender were randomized. Four types of treatment were selected using a multi-therapy approach applied for a duration of five days. Among the medical team in charge of the protocol ten (10) were subjected for prophylactic purposes to a three-day tritherapy treatment. A total of 132 participants received a multi-therapy treatment as curative treatment (122 patients) and as prevention (10 health workers). All participants were tested for RT-PCR before treatment, all patients tested positive while the health workers tested negative. After two weeks all participants tested negative by RT-PCR. Clinical follow-up showed a total and rapid recovery at the early stage of tri-immunotherapy while repeated RT-PCR testing for the participants with preventive treatment remained negative. Conclusion. Such multi-immunotherapy protocols against SARS-CoV-2 efficacy appear substantial for treatment and potentially efficient for health worker prevention. Due to our limited subject and the compassionate context, all multi-immunotherapy protocols would require a control study to evaluate their efficacy.
Authors and Affiliations
Lungu P Anzwal*, Kalumba A Kambote, Tshinawej P Mukiny, Sadiki P Wabula, Moba C Iselenge, Bangutulua V Mbezi, Mokalu S Maope, Jean-Paul J Gonzalez, Balaka M Ekwalanga
Keywords
Related Articles
- EP ID EP699094
- DOI http://dx.doi.org/10.46889/JCIM.2021.2109
- Views 102
- Downloads 0
Can the Info-Energy of a Prayer Boost the Immune System? What Our Science Says?
Every living being is a material body and aura. When the living beings die, they don’t have auras any more. Is the aura the Spirit, which leaves the material body when the living being dies? My lifelong studies found tha...
Review on Cancer and the Immune System
Cancer is a term for a large group of diseases caused by abnormal cells divide rapidly and spread to other tissue and organs. Under normal circumstances, so many cells multiply as long as the body is in need of them for...
Another Wake-up Call for Innovative Research with Vision
An article titled “Why Tuberculosis Has Not Been Eradicated? Need for Vision and bold Innovative Research” published in 2017 was a wake-up call to Health Research Workers (HRWs) to carryout innovative research with vis...
How Does Dexamethasone Work Against the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)?
The continuing COVID-19 pandemic instigated by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) led the scientists discover an array of candidate drugs and set up possible vaccine platforms under trial....
Stop Eating Fast, Keep Staying Last
This article addresses an important abnormal eating behavior or ‘speedy eating’ that can predispose human body to diabesity (diabetes and obesity) development and its associated complexities in the stressful modern times...